Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Congress Urged To Address OMB’s Expanded Role In Regulations, Guidance

This article was originally published in The Tan Sheet

Executive Summary

Government watchdog group OMB Watch is urging Congress to impede the implementation of an executive order that increases the administration's influence over regulations and guidance documents issued by FDA and other agencies

You may also be interested in...



Sunscreen Rule Will Cost Four Times What FDA Predicted, Industry Tells OMB

FDA's low-ball estimate of costs its final OTC sunscreen monograph will impose on industry - a quarter of the amount anticipated by manufacturers - relieved the agency from having to submit a full account of its rulemaking to the Office of Management and Budget, Energizer Holdings suggests

Sunscreen Rule Will Cost Four Times What FDA Predicted, Industry Tells OMB

FDA's low-ball estimate of costs its final OTC sunscreen monograph will impose on industry - a quarter of the amount anticipated by manufacturers - relieved the agency from having to submit a full account of its rulemaking to the Office of Management and Budget, Energizer Holdings suggests

Executive order “defunded”

The House moves to block funding for Executive Order 13422, which would increase Office of Management and Budget oversight over all federal agencies, with legislation passed June 28. Among other things, the order states that OMB has the authority to require notice and review of agency guidance documents (1"The Tan Sheet" Jan. 29, 2007, In Brief). An amendment to an appropriations bill (HR 2829) passed by the House stipulates that "none of the funds made available by this act may be used to implement" the executive order. The bill provides funding for the Treasury Department, Executive Office and general government activities. The amendment was co-sponsored by Science Subcommittee on Oversight Chair Brad Miller, D-N.C., and Judiciary Subcommittee on Commercial and Administrative Law Chair Linda Sanchez, D-Cal., who each held hearings on the executive order in February (2"The Tan Sheet" March 12, 2007, p. 10). No similar action has been taken as yet in the Senate...

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS100291

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel